Proffitt & Goodson »

Regeneron Pharmaceuticals shares owned by Proffitt & Goodson

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Proffitt & Goodson from 13F filings

Historical chart of Proffitt & Goodson investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Proffitt & Goodson consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Proffitt & Goodson

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1k 1 1052.00

More positions owned by Proffitt & Goodson

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Proffitt & Goodson

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
T. Rowe Price Associates
Loomis, Sayles and
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals